What is the role of aztreonam-avibactam in treating infections caused by NDM-producing bacteria?
Aztreonam-avibactam is a promising treatment option for NDM-producing bacterial infections, demonstrated to have strong in vitro activity and fulfilling an unmet need by targeting resistant strains. Clinical studies are needed to confirm its effectiveness in practice.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-16
- DOI
- https://doi.org/10.5281/zenodo.24287135
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00